HEART PEMODELING IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
Abstract
This review is the conbribution levelopment of the left ventricular hypertrophy (LVH) in patients with chronic glomerulonephritis. LVH is found in 75% patients with chronic renal failure (CRF) who started dialysis therapy and it is the prognostically unfavorable factor which has impact on the result jf the disease. At the same time it is known that LVH as a leading risk factor for lethality in patients with terminal CRF can develop even in cases of moderate decrease in renal functions. Its frequency and risk factors in patients with functionally compensated CRF are not fully studied up to now.
Keywords:
hypertension nephropathies, left ventricular hypertrophy, left ventricular remodeling, chronic kidney disease, glomerular filtration rate, chronic heart failure, and echocardiography.References
1. Рябов С.И. Лечение хронической почечной недостаточности // С-Пб. 1997. 435 С.
2. Волгина Е.В. Клиническая этиология кардиоваскулярных нарушений при хронической почечной недостаточности // Нефрология и диализ 2000; 2: 25-32.
3. Дядык А.И., Багрий А.Э., Лебедь И.А. Гипертрофия левого желудочка сердца у больных с хронической почечной недостаточностью // Кардиология 1997; 37(2): 76-81.
4. Смирнов А.В., Добронравов В.А., Каюков И.Г. Кардиоренальный континуум: патогенетические основы превентивной нефрологии // Нефрология 2005; 3:7-15.
5. Нефрология: руководство для врачей. Под ред. И.Е. Тареевой. М.: Медицина, 2000: 688.
6. Buckalew V.M., Berg R.L., Wang S.R., Porush J.G ., Rauch S., Sulman G. Prevalence of hypertension in 1795 subjects with chronic renal disease: the Modification Diet in renal Disease Study baseline cohort// Am. J. Kidney. Dis. 1996; 28:811- 821.
7. Тареев E.M. Истоки нефрологии // Урология и нефрология 1978; 2: 72-75.
8. Volhard F., Fahr Т.Н. Die B rightische Nierenkrankheit. Klinik, Pathologie und Atlas. Berlin, 1914.
9. Volhard F., B lutdruck und N iere, in Nierenkrankheiten // Deutsch Med. Wochenschr. 1940; 66: part I: 426-430, part 2: 452-456.
10. Brenner B.M., Meyer T.W., Hostetter Т.Н. Dietary protein intake and progressive nature of kidney disease: The role of hemodinamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease // New Engl. J. Med. 1982; 307: 652- 660.
11. Brenner B.M. Hemodinamically mediated glomerular injury and the progressive nature of kidney disease // Kidney Int. 1983; 23: 647- 655.
12. Brenner B.M. Nephron adaptation to renal njury or ablation//Am. J. Physiol. 1985; 249: 324- 337.
13. Brenner B.M., Garsia D.L., Anderson S. Glomeruli and blood pressure. Less of one, more of the other? // Am. J. Hypertens. 1988; 1: 335-347.
14. Levin A., Singer J., Thompson C.R. et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention //' Am. J. Kidney Dis. 1996; 27: 347- 354.
15. Marabotti C., Ebert A.G., Palombo C. et al. Causal, ambulatory and stress blood pressure: relationship with left ventricular mass and filling // Int. J. Cardiol. 1991; 31: 89-96.
16. Canau A., Devereux R.B., Roman M.J. et al. Petterns o f left ventricular hypertrophy and geometric remodeling in essential hypertension //. J. Am. Coll. Cardiol. 1992; 19:1550- 1558.
17. Verdecchia P., Porcellati C., Zampi I. et al. Asymmetric left ventricular remodeling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular masses // Am. J. Cardiol. 1994;73:247-252.
18. Krum holz H.M ., Larson М., Levy D. Prognosis of left ventricular geometric patterns in Framingham heart study // J. Am. Coll. Cardiol. 1995;25:879-884.
19. Карпов PC., Пузырев К.В., Павлюкова Е.Н., Степанов В. А. Молекулярно-генетический анализ гипертрофии миокарда левого желудочка // Кардиология 2001; 6: 25-30.
20. Cohn J.N. Structural basis for heart failure: ventricular remodeling and its pharmacological inhibition // Circulation 1995; 91: 2504-2507.
21. Gerdes A.M , Capasso J.M . Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure U J. Mol. Cell. Cardiol. 1995; 27: 849-856.
22. Рязанов А.С., Смирнова М.Д., Юренев А.П. Гипертрофия миокарда левого желудочка.- Вопросы патогенеза//Тер. арх. 2000; 2: 672-677.
23. Opie L.H. Mechanisms of cardiac contraction and relaxation. In: Braunwald's heart disease: a textbook of cardiovascular medicine. Ed. D. Zipes, P. Libby, R.O. Bonow, Braunwald E. 7th ed. Pensylvania: Elsevier Saunders, 2005: 457-490.
24. Young E.W., Carroll L.E., Wolfe R.A. et al. Trends in comorbidity and residual renal function in patients starting treatment for end-stage renal disease // J. Am. Soc. Nephrol. 1995; 6: 897.
25. Eckardt K.-U., Clyne N., Drueke T. et al. Variables of left ventricular geometry and function in patients enrolled in the create trial // In ERA- EDTA XXXIX Congress, Copenhagen 2002; abstract 136.
26. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE et al. Blood pressure and end-stage renal disease in men // N. Engl. J. Med. 1996. - V. 334. N. 1. - P. 13-18.
27. Jungers P., Massy Z.A., Nguyen-Khoa T. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients //Nephrol. Dial. Transplant. 2001; 16: 2357-2364.
28. Levin A., Singer J., Thompson C.R. et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention // Am. J. Kidney Dis. 1996; 27: 347- 354.
29. Foley R.N., Parfrey PS., Hurnett J.D. et al. Im pact o f hypertension on cardiom iopathy, morbidityand mortality in end-stage renal disease / /Kidney Int. 1996; 49: 1379-1385.
30. Сидоренко Б.А., Преображенский Д.В. Гипертрофия левого желудочка: патогенез, диагностика и возможность обратного развития под влиянием антигипертензивной терапии //Кардиология 1998;5: 80-84.
31. Рекомендации по диагностике и лечению хронической сердечной недостаточности. Доклад экспертной группы по диагностике и лечению хронической сердечной недостаточности Европейского общества кардиологов // Сердечная недостаточность 2001; 6: 251-276.
32. Devereux R.B., ReichekN. Echocardiografic and its regresson // London. 1992. P. 1-11.
33. Foley R.N., Parfrey P.S., Harnett J.D. et al. The prognostic im portance o f left ventricular geometry in uremic cardiomyopathy // J. Am. Soc. Nephrol. 1995; 5: 2024 2031.
34. Grossman W. Cardiac hypertrophy: useful adaptation or pathological process? // Am. J. Med. 1980; 69: 576-584.
35. Foley R.N., Parfrey PS., Harnett J.D. et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy // Kidney Int. 1995; 47: 186-192.
36. Cannella G., Paoletti E., Ravera G. et al. Inadequate diagnosis and therapy o f arterial hypertension as causes o f left v en tricular hypertrophy in uremic dialysis patients // Kidney Int. 2000; 58: 260.
37. Mann J.F., Gerstein H.C., Pogue J. et al. Cardiovascular risk in patients with early renal insufficiency: implications forthe use of ACE inhibitors // Am. J. Cardiovasc. Drugs. 2003; 2(3): 157-162.
38. AnavekarN.S., Pfeffer M.A. Cardiovascular risk in chronic kidney disease // Kidney Int. 2004; 66 (92): 11-17.
39. Go A.S., Fan D., Chertow G.M. et al. Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization //N . Engl. J. Med. 2004; 351 (13): 1296-1305.
40. Sarnak M.J., Levey A.S. Cardiovascular disease and chronic renal disease: a new paradigm / /A m . J. Kidney Dis. 2000; 35(1): 117-131.
41. Волгина Г.В. Клиническая эпидемиология кардиоваскулярных нарушений при хронической почечной недостаточности // Нефрология и диализ 2000; 2 (1-2): 25-32.
42. Parfrey PS., Foley R.N., Harnett J.T., Kent G.M., Murray D., Barre PE. Outcome and risk factors for left ventricular disorders in chronic uremia // Nephrol. Dial. Transpl. 1996; 11: 1277-1285
43. Иванов Д.Д. Поражение почек как фактор риска кардиоваскулярных осложнений: акцент на блокаду РААС // Здоровая Украина 2008; 2: 14-15.
44. Weiner D.E., Tighiouart Н., Elsayed E.F., Griffith J. L., Levey A.S., Sarnak M.J. et al. Clinical research: C oronary risk stratificaition. The Framingham Predictive Instrument in Chronic Kidney Disease // Am. J. Kidney Dis. Manuscript received December 12, 2006; revised manuscript received March 9, 2007, accepted March 13, 2007.
